Drug profile · INN
icosapent ethyl
VAZKEPA
icosapent ethyl (VAZKEPA) is a unknown. Associated with Seqirus (Australia) Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — icosapent ethyl
- US status
- approved
- Class
- Cardiovascular system (C10)
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
icosapent ethyl (VAZKEPA) is a unknown. Associated with Seqirus (Australia) Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
| TGA | approved | — |
Recent coverage
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is icosapent ethyl?
icosapent ethyl (VAZKEPA) is a unknown. Associated with Seqirus (Australia) Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for icosapent ethyl?
VAZKEPA is a marketed brand name for icosapent ethyl. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of icosapent ethyl?
icosapent ethyl has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.